Related Experiment Video

Updated: May 22, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

[Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis]

Tomoo Kise1, Hiroshi Yoshimura

  • 1Department of Pediatric Nephrology, Prefectural Okinawa Nanbu Medical Center and Children's Medical Center, Japan.

Nihon Jinzo Gakkai Shi
|May 18, 2012
PubMed
Abstract

Insights

Mycophenolate mofetil (MMF) effectively treats severe lupus nephritis in children. This therapy improved kidney function and reduced disease markers during induction and maintenance phases.

Area of Science:

  • Pediatric Nephrology
  • Autoimmune Diseases
  • Immunosuppressive Therapy

Background:

  • Juvenile onset lupus nephritis is a severe autoimmune condition affecting children's kidneys.
  • Current treatment protocols require evaluation for improved efficacy and safety.
  • Mycophenolate mofetil (MMF) is an immunosuppressant with potential in lupus nephritis management.

Purpose of the Study:

  • To assess the efficacy of mycophenolate mofetil (MMF) in treating juvenile onset severe lupus nephritis.
  • To evaluate MMF's role in both the induction and maintenance phases of therapy.
  • To determine the impact of MMF on clinical and laboratory markers of lupus nephritis.

Main Methods:

  • A cohort of children with severe focal and diffuse proliferative lupus nephritis received MMF and prednisolone.
  • Treatment duration was 24 months, including a 6-month induction and 18-month maintenance phase.
  • Efficacy was monitored through urinalysis, renal function tests, albumin levels, and serological markers (anti-dsDNA, C3, C4).

Main Results:

  • Induction therapy with MMF led to significant reductions in urine protein and anti-dsDNA antibodies, alongside improved renal function and albumin levels.
  • During maintenance therapy, no renal flares were observed, and MMF was well-tolerated with no discontinuations.
  • Renal histology showed improvement in 4 out of 5 patients who underwent a second biopsy post-MMF treatment.

Conclusions:

  • Mycophenolate mofetil (MMF) demonstrates significant efficacy as both an induction and maintenance therapy for juvenile onset severe lupus nephritis.
  • MMF offers a promising therapeutic option for pediatric patients with this serious kidney disease.
  • The study supports the use of MMF in managing severe lupus nephritis in children, showing positive clinical and histological outcomes.

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...